CLENPEX 40 SIXPEX at a Glance
CLENPEX 40 SIXPEX is a research-grade clenbuterol preparation developed for laboratory investigation of beta-2 adrenergic receptor mechanisms and metabolic pathways. Clenbuterol is a selective beta-2 agonist that has been extensively studied in preclinical research for its effects on thermogenesis, lipolysis, and cellular energy expenditure. This SIXPEX formulation provides researchers with a standardised tool for examining beta-adrenergic signalling cascades and metabolic modulation in controlled laboratory environments. The compound’s selectivity for beta-2 receptors makes it valuable for investigating tissue-specific adrenergic responses and understanding the molecular mechanisms underlying sympathomimetic activity. Research applications span cellular metabolism studies, receptor binding assays, and thermogenic pathway investigations.
Laboratory Applications
Research scientists utilise CLENPEX 40 for studying beta-2 adrenergic receptor activation and downstream signalling pathways in various experimental models. The compound serves as a research tool for investigating cyclic adenosine monophosphate (cAMP) elevation, protein kinase A activation, and subsequent metabolic cascades in cellular systems. Laboratory studies have examined clenbuterol’s effects on lipolytic enzyme activation, uncoupling protein expression, and mitochondrial thermogenesis in adipocyte cultures. Researchers at Stroid UK Shop can access this preparation alongside other metabolic modulators for comparative analysis. The compound’s stability and consistent bioactivity make it suitable for dose-response studies, receptor binding investigations, and mechanistic research into sympathomimetic pathways. Studies have explored its interaction with thermogenic compounds and its potential synergistic effects with other research chemicals in metabolic research protocols.
Compound Specifications
| Compound Name | Clenbuterol (as CLENPEX 40) |
|---|---|
| CAS Registry | 37148-27-9 |
| Molecular Formula | C₁₂H₁₈Cl₂N₂O |
| Molecular Weight | 277.19 g/mol |
| Classification | Beta-2 adrenergic agonist |
| Manufacturer | SIXPEX |
| Storage Conditions | Room temperature, dry environment |
| Research Use | In-vitro laboratory studies only |
This preparation demonstrates consistent activity in beta-2 receptor binding assays and maintains stability under standard laboratory storage conditions. Researchers investigating metabolic pathways can complement studies with selective androgen receptor modulators or research peptides for comprehensive metabolic research protocols.
Research Compliance Statement
CLENPEX 40 SIXPEX is manufactured exclusively for in-vitro research applications and laboratory analysis. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with applicable regulations governing research chemical handling and institutional review board requirements. All investigations should be conducted by qualified personnel in appropriately equipped laboratory facilities with adequate safety protocols and waste disposal procedures.

